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The present work is a structure-function study of an enzyme Ecm18 involved in the 
biosynthesis of an antibiotic and antitumor compound called echinomycin. Apart from 
possessing antitumor activity, echinomycin is known for its remarkable pharmaceutical 
properties. 
Echinomycin belongs to a large family of complex natural products called nonribosomal 
peptides (NRPs). One of the most important subfamily of NRPs is the family of compounds 
called quinomycins. Quinomycin group of compounds possess potent antiviral, antibacterial 
and antitumor properties. They are DNA-intercalating agents and are characterised by the 
presence of a unique chemical group called the thioacetal group. The presence of this 
chemical group provides better stability to the quinomycins over other closely related 
compounds. It is because of this reason the quinomycins have become important 
pharmaceutical drug candidates. 
Echinomycin is a member of this very remarkable class of compounds. It has antibacterial 
and antitumor properties and has recently gained prominence as an important antitumor drug 
candidate. 
In a recent investigation carried out in 2006 (Watanabe K 2006), the complete biosynthetic 
pathway of echinomycin was uncovered in the bacterium Streptomyces lasaliensis. Here they 
have made an interesting discovery that the final step in the biosynthetic pathway of 
echinomycin involves an unprecedented biotransformation (disulfide bond to thioacetal 
group) in which methylation and subsequent bond rearrangement lead to the formation of 
echinomycin. They found that a single enzyme was responsible for this unique conversion 
which was later identified to be Ecm18. 
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Ecm18 is the first reported natural enzyme, to catalyse this unique biotransformation. It has 
39% sequence identity with a known methyltransferase. But other details regarding this 
protein could not be obtained from the available sequence information. In order to get a 
detailed understanding of the catalytic mechanism of this enzyme, we sought to study its 
structure using X-ray crystallography. 
Ecm18 protein was heterologously expressed in E.coli system and purified for the purpose of 
crystallisation. The enzyme was successfully captured in its crystallised form in complex 
with its product and by-product and a high-resolution (1.5 Å) diffraction dataset was 
collected for the crystal. The structure of the ternary complex was determined from the 
diffraction data and it is currently being refined. 
With the partially refined structure, we have made preliminary investigations regarding the 
architecture of the enzyme. Ecm18 possesses a well conserved Rossmann-like fold found in 
many methyltransferases, whereas its substrate binding domain is not conserved. Apart from 
the structural information obtained, an interesting observation was made from the ternary 
complex structure. Echinomycin in complex with the enzyme Ecm18 has a folded 
conformation whereas in the previously determined structures of echinomycin (echinomycin 
in complex with oligonucleotides), it is in an extended conformation.  
We have also identified the putative residues of Ecm18 that are involved in catalysis. Based 
on the observations and interpretations, we propose a plausible catalytic mechanism of 
Ecm18. The presence of Rossmann-like fold and the linear arrangement of product and by-
product indicate methyl transfer by nucleophilic attack. His-115 has been identified as a 
putative catalytic base involved in a proton abstraction step. Two aromatic residues Phe-5 and 
Trp-21 have been identified to have plausible role in catalysing an important step in the 
biotransformation. Further studies must be carried out to confirm the proposed mechanism. 
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1.1 Nonribosomal peptides 
Microorganisms such as actinobacteria, myxobacteria and filamentous fungi produce a 
variety of bioactive natural products with antibacterial, antiviral, immunosuppressive, 
antitumor and antifungal activities (Takusagawa 1985).  One such class of compounds is 
called the nonribosomal peptides (NRPs). The members of this group contain unique 
structural features such as D-amino acids and heterocyclic elements, characteristic of their 
nonribosomal synthesis (Takahashi K 2001; Sieber and Marahiel 2005) (Figure 1). 
 
 
Figure 1. Examples of nonribosomal peptide natural products. Nonribosomal peptide natural products 
contain unique and diverse chemical groups which are attached to the peptide backbone. For example, 
vancomycin contains a disaccharide unit, bacitracin contains heterocyclic group, pristinamycin has N-





1.1.1 Nonribosomal peptide synthesis 
Although the NRPs vary widely in their structural features, their biosynthetic pathway 
classically involves multienzyme complexes called nonribosomal peptide synthatases usually 
encoded on a single gene cluster. The multienzyme machinery is divided into different 
modules and each of the modules is required for the incorporation of specific amino acid 
residue which forms the building block of the peptide scaffold (Figure 2). There are different 
structural domains in these modules which are responsible for substrate recognition, 
activation, chemical group modifications, chain elongation, cyclisation and various other 
functions.  (Sieber and Marahiel 2005; Strieker, Tanovic et al. 2010). 
 
 
Figure 2. Nonribosomal peptide synthesis involving multienzyme complex machinery. Schematic 
representation of multienzyme machinery involved in NRP synthesis. The modular architecture of the 
multienzymes is depicted in this figure (Sieber and Marahiel 2005).  
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1.2 Quinomycin antibiotics 
Quinoxaline or quinoline antibiotics, falling under the class of nonribosomal peptide products 
contain bicyclic aromatic chromophores (quinoxaline) associated with them. They are 
bifunctional DNA intercalating agents with inhibitory roles in DNA replication and DNA- 
directed RNA synthesis (Lee and Waring 1978; Foster, Clagett-Carr et al. 1985). Many of the 
known antibiotics of this category show potent cytotoxic effect on cultured tumour cells with 
nanomolar potencies (Boger, Ichikawa et al. 2001).  The quinomycins form an important 
subclass of quinoxaline antibiotics and their importance is attributed to the presence of a 
chemical group called the thioacetal group which is unique to this class of compounds 
(Martin, Mizsak et al. 1975).  
 
1.3 Echinomycin 
Echinomycin (quinomycin A) is an important member of quinomycin (Figure 3) . It is an 
antibacterial and antitumor agent and like all other quinomycins exhibits its activity by 
intercalating to DNA bases. Echinomycin has specific affinity to bind to (G+C) rich regions 
in DNA. It has recently gained prominence as an important candidate for cancer research ever 
since it was identified as a small molecule inhibitor of Hypoxia Inducible Factor-1’s  (HIF-1 
DNA-binding activity (Kong, Park et al. 2005). HIF-1 is a transcription factor which controls 
the transcription of genes involved in tumor progression and metastasis. Echinomycin binds 
to DNA regions in sequence specific manner and blocks HIF-1 from exhibiting its activity. 




 In the present study, the focus is on the structural study of the enzyme Ecm18 involved in the 
final step of the biosynthetic pathway of echinomycin.  
1.3.1 Biosynthesis of echinomycin 
The biosynthesis of echinomycin follows parallel pathways by multienzyme complex 
encoded by a gene cluster in a single plasmid (Sieber and Marahiel 2005). The quinoxaline 
chromophore (QC) is produced from L-tryptophan by 8 different enzymes (Ecm 14, Ecm13, 
Ecm12, Ecm11, Ecm 8, Ecm4, Ecm3 and Ecm2). The synthesized QC is attached to acyl 
carrier protein which is added as the first residue to NRP synthesizing multimeric complex.  
The depsipeptide core is synthesized as dimer and cyclisation of the dimer terminates the 
synthesis (Ecm6 and Ecm7). The depsipeptide core with the QC forms the first class of 
compounds in which Cys residues in the cyclic peptide do not form the bridge. Following this 
synthesis Ecm17 causes the oxidation of the Cys forming the disulfide bridge producing 
triostin A (Foster, Clagett-Carr et al. 1985). Further, this disulfide bridge is converted to 
thioacetal bridge by the enzyme Ecm18, giving rise to the echinomycin (Figure 4) (Watanabe 
K 2006). 
 
Figure 3. Structure of echinomycin. 
It is a cyclic peptide (NRP). 
Structural characteristic features 
include the quinoxaline 
chromophores (marked in blue 
circles) and the thioacetal bridge 




Figure 4. Biosynthetic pathway of echinomycin in Streptomyces lasaliensis. The precursor molecule 
in echinomycin synthesis is L-Tryptophan; (ii) QC chromophore is produced from L-Tryptophan by 
the action of 8 enzymes – Ecm14, Ecm13, Ecm12, Ecm11, Ecm8, Ecm4, Ecm3 and Ecm2; (iii) QC 
chromophore is attached to acyl carrier protein to produce depsipeptide; (iv) The depsipeptides are 
synthesized as dimers; (v) Cyclisation of dimers catalysed by Ecm 7; (vi) Synthesis of triostin A with 
disulfide bond catalysed by Ecm17; (vii) Synthesis of echinomycin with thioacetal bond catalysed by 
Ecm18 (Sieber and Marahiel 2005; Watanabe K 2006). 
 
1.3.2 Importance of thioacetal bridge 
Triostin A and echinomycin, bis-intercalate DNA with different binding abilities and 
sequence specificities. Echinomycin preferentially binds to CG-rich regions whereas triostin 
A binds to AT rich segments (Lee and Waring 1978; Foster, Clagett-Carr et al. 1985). These 
variations may arise due difference in their conformations in solution which is attributed to 
the thioacetal bridge. 
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The unique structural conversion results in minute structural changes which in turn lead to 
interesting biological consequences. The cross bridge between the cyclic peptides is shorter 
in echinomycin than in triostin A. Certain amino acid residues between the two molecules 
show minor deviation between the two structures (Figure 5).  
The conformational constrain imposed by the thioacetal bridge confers better properties to 
echinomycin in terms of its stability and DNA binding affinity (Lee and Waring 1978; 
Ughetto, Wang et al. 1985; Cuesta-Seijo and Sheldrick 2005).  
  
Figure 5. Comparison of the structures of triostin A and echinomycin. (a) Structures of triostin A and 
echinomycin in complex with (CGTACG)2 oligonucleotide. The difference in the length of the cross 
bridge between the two molecules is displayed; Triostin A and echinomycin are represented in sticks. 
Triostin A is coloured in pink and echinomycin in cyan; (b) Superimposition of the crystal structures 
of triostin A and echinomycin. Minor deviations in the side chain of amino acids in the two structures 
are displayed. 
 
Hence studying the enzyme bringing about this change would provide a great deal of 
information regarding the general synthesis of this unique group of compounds. Sequence 
information of Ecm18 reveals that this enzyme has a SAM binding domain and is classified 
as a SAM-dependent MTase (SAM-dependent MTase). The biotransformation of triostin A to 
echinomycin involves methylation as well as an energetically unfavourable bond 
rearrangement step catalysed by a single enzyme Ecm18. To date, Ecm18 is the first and the 
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only identified natural enzyme carrying out this unique chemical group conversion. The 
mechanism behind such a biotransformation has not been studied so far. 
From the knowledge of the general catalytic mechanism of SAM-dependent MTases, the 
mechanism of methylation reaction catalysed by Ecm18 can be obtained. 
 
1.4 SAM dependent methylation 
S-Adenosyl methionine (SAM) or AdoMet (Figure 6) is the common methyl group donor, 
involved in the numerous biological functions. It’s the second abundantly found co-factor in 
cells followed by ATP. The other methyl donors found in the biological system are folates 
and betaines which are used in few of the methyl transfer reactions (Cheng and Blumenthal 
1999). 
 SAM plays an important role in various cellular physiological processes, biosynthetic 
pathways through methylation of various biological molecules such as small molecules, 
lipids, proteins, DNA, RNA and polysaccharides. These reactions are mediated by highly 




Figure 6. S-Adenosyl methionine (SAM). 
SAM has a positively charged sulfonium 
ion which bears the methyl group. The 
transfer of methyl group from the 
positively charged sulfonium ion to the 
acceptor molecule is mediated by SAM-
dependent MTases (Lin 2011).  
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1.4.1 Different mechanisms of methyl transfer 
The mechanism of transfer of methyl group from SAM to the acceptor molecule can be 
broadly classified into two types – by nucleophilic substitution or via the formation of a 
free-radical intermediate. The mode of methylation mediated by these MTases depends on 
the overall structural fold adopted by these enzymes (Kozbial and Mushegian 2005). 
1.4.2 Structural basis for methyl transfer by SAM-dependent MTases – Rossman fold 
and TIM barrels 
The amino acid sequence of the SAM-dependent MTases is not highly conserved across the 
members of this class. But these proteins share a common core structural fold in the SAM 
binding region whereas the substrate binding region exhibits considerable variation in the 
sequence and structure (Schubert, Blumenthal et al. 2003). The diversity in the structural 
folds observed in the substrate binding domains can be explained by their need to bind a 
variety of substrates and variation in the chemistry of reactions. 
There are two common structural folds repeatedly seen among these proteins – Rossmann-
like fold and TIM barrel. The two different folds account for the two different mechanisms 
adopted by these enzymes to carry out the chemical transformations. The majority of the 
MTases contain Rossmann-like fold with a few members adopting the TIM barrel like fold 
(Kozbial and Mushegian 2005). 
1.4.3 Rossmann-like fold facilitates nucleophilic substitution 
The basic Rossmann fold consists of α-helices and β-strands placed alternatively to form the 
α6β6 core. The relatively planar β-sheet forms the centre of the core with α-helices on both 
sides of the plane. The major difference between the Rossmann fold proteins and the SAM-
dependent MTases is the insertion of a 7
th
 antiparallel β-strand into the sheet between the 
strands. The overall topology of the strands in these MTases is 3214576 (Martin and 
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McMillan 2002; Kozbial and Mushegian 2005). Figure 7 shows the overall Rossman-like 
fold topology of SAM-dependent MTases. 
 
Figure 7. Rossmann-like fold in SAM-dependent methyltransferases (MTases). (a) Topology diagram 
of the core Rossmann fold; (b) Topology diagram of the SAM-MT fold. The seventh antiparallel β-
strand in SAM-MT fold is represented in purple; (c) Ribbon representation of SAM-dependent 
MTases exhibiting the core Rossmann fold. The Rossmann fold is coloured in slate; the seventh 
antiparallel β-strand is coloured in purple; the substrate binding domain is coloured in limegreen. The 
proteins are denoted by their name and PDB code. Rebeccamycin, a sugar O-methyltransferase from 
Lechevalieria aerocolonigenes (PDB code – 3BUS), DphI, a phosphonate O-methyltransferase from 
Streptomyces ludicrous (PDB code -3OU2), Glycine N-methyltransferase from Rattus norvegicus 
(PDB code-1BHJ), Catechol O-methyltransferase from Rattus norvegicus (PDB code-1VID). The 
protein structures in this figure and the following figures are prepared using PyMOL. 
 
 
These MTases catalyse the methyl transfer via nucleophilic substitution. Nucleophilic 
substitution happens when the acceptor atom has a lone pair of electrons, such as N, O and S. 
The lone pair of electrons attack the methyl group bonded to the electron deficient sulfur 




Figure 8. Methyl transfer by nucleophilic substitution. SAM-dependent MTases with Rossmann-like 
fold catalyse methylation of the nucleophiles such as N,O and S via the classic SN2 mediated 
nucleophilic substitution (Lin 2011). 
 
1.4.4 TIM barrel fold facilitates free radical formation 
In 2001 (Sofia, Chen et al. 2001), a new class of SAM-binding proteins called the “radical 
SAM enzymes” were discovered which use novel chemical mechanisms to carry out their 
diverse functions apart from methylation. These enzymes have either TIM barrel - (β/α)8 
fold or “semi barrel” (β/α)6 fold that forms the SAM-binding domain (Figure 9).  
The amino acid sequence in these proteins is characterized by the presence of a highly 
conserved “CXXXCXXC” motif near the N-terminus. This motif co-ordinates with an [Fe-
S]4 cluster and the SAM binding region is positioned very close to this motif. The amino acid 
residues in the C-terminal region do not show sequence conservation and they are mostly 
involved in substrate binding and other co-factor binding (Layer, Heinz et al. 2004; Wang 





Figure 9. TIM barrel fold in radical SAM enzymes. (a) Topology diagram of TIM barrel fold; (b) 
Ribbon representation of radical SAM enzymes exhibiting TIM barrel and semi barrel fold. The 
proteins are denoted by their name and PDB code. HyDE , Fe-Fe-hydrogenase maturase from 
Thermotoga maritime (PDB code-3IIZ), TYW1, a tRNA base modifying enzyme from 
Methanocaldococcus jannaschii (PDB code-2Z2U), BioB a biotin synthase from Escherichia coli  
(PDB code-1R30), RlMN, a rRNA modifying enzyme from Escherichia coli K-12 (PDB code-3RF9). 
 
Methyl transfer by radical SAM enzymes is mediated via the transient cleavage of SAM to 
5’- deoxyadenosyl radical which in turn causes the abstraction of proton to generate substrate 
radical intermediates. The 5’- deoxyadenosyl radical is formed via the electron transfer from 
the Fe-S cluster in the enzyme (Figure 10) which subsequently leads to the downstream steps 
(Wang and Frey 2007; Grove, Benner et al. 2011). 
 
Figure 10. Methyl transfer through the formation of free radical intermediate. Radical SAM enzymes 
with TIM barrel fold catalyse methyl transfer reactions in the presence of [Fe-S]4 cluster by forming 
free radical intermediate (5’- deoxyadenosyl radical) of SAM (Stubbe 2011). 
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The overall α/β architecture between the two classes of MTases is similar. But the radical 
SAM MTases lack one α-layer present in the TIM barrel and the difference is reflected in the 
curvature of the sheet and orientation of strands (Kozbial and Mushegian 2005). All these 
structural variations lead to a change in the way the two classes of enzymes interact with 
SAM and hence the difference in the mechanism of reaction catalysed. 
 
1.5 Bioinformatics analysis 
Pfam A has identified Ecm18 from Streptomyces lasaliensis (Uniprot ID: Q0X0A7) to be a 
putative SAM-dependent MTase (Methyltransferase_31 (PF13847)) (Figure 11). PSI-
BLAST results of Ecm18 show many putative hypothetical proteins and MTases  with the 
top-most hit being a putative SAM-dependent MTase from Streptomyces triostinicus with 
68% sequence identity (refer Appendix 2). PfamA domain prediction predicts the presence of 
a MTase domain in Ecm18 from residue 42 to 145. 
 
Figure 11. Ecm18 sequence analysis using PfamA domain prediction. PfamA predicts the presence of 
a well conserved MTase domain from 42 to 145 in Ecm18. Ecm18 has been classified under the 





NCBI’s conserved domain database predicts the presence of a SAM binding site in Ecm18 
(Figure 12). NCBI’s CD-search tool which is used for identifying amino acid residues that 
are putatively involved in substrate binding and catalysis did not identify any conserved 
residues in Ecm18. 
 
Figure 12. Ecm18 sequence analysis using NCBI conserved domain database (NCBI-CDD). NCBI-
CDD classifies Ecm18 as an AdoMet-dependent MTase (SAM-dependent MTase). The region of 





1.5.1 Secondary structure prediction 
Ecm18 sequence analysis does not indicate the presence of an iron-sulfur binding motif. The 
secondary structure prediction for Ecm18 was carried out using PSIPRED (McGuffin, Bryson 
et al. 2000). The result of this analysis shows the presence of 7 α-helices and 8 β-strands and 
suggests the presence of Rossmann-like fold in Ecm18 (Figure 13). 
 
 
Figure 13. Secondary structure prediction for Ecm18. Secondary structure prediction was carried out 
using the PSIPRED. The helices are represented as pink cylinders, strands as yellow arrows and the 





1.5.2 Homology modelling 
Homology modelling of Ecm18 was carried out using the software MODELLER (Eswar, 
Webb et al. 2006). This analysis predicts the presence of Rossmann-like fold in Ecm18 
(Figure 14). 
 
Figure 14. Homology model of Ecm18. Ribbon representation of the homology model of Ecm18. 
Template model is DhpI, a phosphonate O-MTase from Streptomyces luridus (PDB code – 3OU2). 
The sequence identity between Ecm18 and DhpI is 32%. The model generated predicts the presence 
of 8 α-helices and 9 β-strands in Ecm18. The core α/β Rossmann fold is coloured in lightpink, the 
seventh antiparallel β-strand characterising the SAM-MT fold is coloured in cyan, the substrate 
binding domain is coloured in marine. 
 
1.5.3 Sequence comparison with homologous proteins 
Search for structural homologues for Ecm18 using PDB-BLAST identifies a SAM-dependent 
MTase from Pyrococcus horikoshii OT3 (PDB code – 1WZN) as the closest structural 
homologue which has 39% sequence identity. Other significant hits include a putative MTase 
–PH0226 from Pyrococcus horikoshii OT3 (PDB code – 1VE3), Rebeccamycin, a sugar O-
MTase from Lechevalieria aerocolonigenes (PDB code – 3BUS) and DphI, a phosphonate O-
17 
 
MTase from Streptomyces luridus (PDB code- 3OU2). Multiple sequence alignment of 
Ecm18 with close homologues reveals the conservation of three amino acid sequence motifs 
that are involved in SAM-binding (Figure 15) (O'Gara, McCloy et al. 1995; Schluckebier, 
O'Gara et al. 1995; Kozbial and Mushegian 2005). 
 
Figure 15. Multiple sequence 
alignment of Ecm18 with structurally 
close homologues. Protein sequences of 
structurally characterized MTases are 
denoted by their name and PDB code. 
Ecm18 from Streptomyces lasaliensis, 
Ph0226 protein from Pyrococcus 
Horikoshii Ot3 (PDB code-1VE3), 
SAM-dependent MTase from 
Pyrococcus horikoshii OT3 (PDB code 
-1WZN), Rebeccamycin, a sugar O-
MTase from Lechevalieria 
aerocolonigenes (PDB code – 3BUS), 
SAM-dependent MTase 
Q8Puk2_memta from Methanosarcina 
mazei Go1 (PDB code – 3SM3), DphI, 
a phosphonate O-MTase from 
Streptomyces ludicrous (PDB code -
3OU2), TehB from Haemophilus 
influenza (PDB code – 3M70), Tellurite 
detoxification protein TehB from 
Escherichia coli str. K-12 
substr.MG1655 (PDB code – 2XVA), 
SAM-dependent MTase 
ZP_00538691.1 from Exiguobacterium 
sp. 255-15 (PDB code-3D2L), putative 
MTase from Salmonella typhimurum 
lt2 (PDB code- 2I6G), MTase domain 
of trimethylguanosine synthase TGS1 
from Homo sapiens (PDB code – 
3EGI) . Sequence motifs in the SAM-
binding domain that are conserved 
across the proteins are labelled above 
the alignment (Motifs 1,2 and 3). Red 
highlight denotes the amino acid 
residue conserved across all MTases.  
Red font indicates residues that are 
moderately conserved across MTases. 
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Sequence alignment of Ecm18 with the structural homologues suggests that Ecm18 belongs 
to a large super-family of proteins called SAM-dependent MTases but does not identify a 
specific sub-family within this class. 
Hence structural characterisation of Ecm18 is of vital importance to answer some of the 
unanswered questions with regard to the conversion of triostin A to echinomycin and to 




1) To determine the atomic structure of Ecm18 using X-ray crystallography. 
2) To understand the catalytic mechanism of disulfide to thioacetal group transformation 

























Chapter 2 Materials and Methods  
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2.1 Cloning of Ecm18 gene 
The gene encoding the protein Ecm18 was cloned into the PET-28b vector digested by 
NdeI/EcoRI and cloned under T7 promoter with two terminal histidine tags (was obtained 
from our collaborator - Kenji Watanabe, University of Southern California).  The gene was 
originally taken from the bacterium Streptomyces lasaliensis (Uniprot ID: Q0X0A7). The 
gene was cloned with a thrombin cleavage site near the N-terminal to cleave one of the 
histidine tags. 
 
2.2 Expression of recombinant protein 
The expression of recombinant Ecm18 protein was carried out by preparing an overnight seed 
culture in E coli BL21 (DE3) cells in LB media containing kanamycin at 37 °C. 5 ml of 
overnight seed culture was later inoculated in 1 litre of fresh LB media containing 
kanamycin. The cells were allowed to grow until they reached the mid-log phase (OD600 of 
0.7 to 0.8). The culture was then placed on ice for 15 minutes. 1 ml of uninduced expression 
control was taken, centrifuged and the pellet was stored at 4 °C. Over expression of the 
recombinant protein was induced by adding IPTG (Sigma) to a final concentration of 200 µM 
and the induction was carried out at 15 °C for 18 to 20 hours. 1 ml of induced sample was 
taken for checking the expression, centrifuged and the pellet was stored at 4°C. The rest of 
the cells were harvested by centrifugation at 8,600 RCF for 20 minutes at 4 °C. The cell 





2.3 Purification of recombinant Ecm18 
The frozen cell pellet was thawed and resuspended in buffer containing 10 mM sodium 
phosphate pH 7.8, 50 mM NaCl, 6 mM MgCl2, 10% v/v glycerol.  To lyse the cells, CaCl2, 
recombinant lysozyme and benzonase were added to a final concentration of 2 mM, 30 KU/µl 
and 25 U/µl respectively. The cells were allowed to lyse by incubating at room temperature 
for 30 minutes with occasional stirring. The cells were further lysed by sonicating on ice at 
30% amplitude (10 second pulse, 20 second cooling & swirling, 6 times). The cell lysate was 
later obtained by centrifugation at 20,000 RCF for 40 min at 4 °C. 
The supernatant was quickly transferred to a new tube containing washed nickel resin for the 
first step of purification by immobilized metal (Ni
2+
) affinity chromatography. The slurry was 
batch-loaded at 4 °C for 1 hour. The slurry was later poured into an empty column and the 
flow through was collected. The resin with the bound protein was initially washed with 10 
column volumes of load buffer (50 mM sodium phosphate pH 7.8, 300 mM NaCl, 10% v/v 
glycerol, 10 mM imidazole pH 7.8, 15 mM -mercaptoethanol).  It was later washed with 10 
column volumes of wash buffer 1 (50 mM sodium phosphate pH 7.8, 300 mM NaCl, 10% v/v 
glycerol, 15 mM -mercaptoethanol and 20 mM imidazole pH 7.8), and eluted with 2 column 
volumes of elution buffer 1 (50 mM sodium phosphate pH 7.8, 300 mM NaCl, 10% v/v 
glycerol, 15 mM -mercaptoethanol and 100 mM imidazole pH 7.8) and 2 column volumes 
of elution buffer 2 (50 mM sodium phosphate pH 7.8, 300 mM NaCl, 10% v/v glycerol, 15 
mM -mercaptoethanol and 250 mM imidazole pH 7.8). Finally the resin was stripped off the 
remaining protein using 4 column volumes of strip buffer (50 mM sodium phosphate pH 7.8, 
300 mM NaCl, 10% v/v glycerol, 15 mM -mercaptoethanol and 1 M imidazole pH 7.8). The 
fractions from all the washes and the eluates were collected and checked for the presence of 
protein by running on a 4-12% SDS-PAGE gel (Figure 16). 
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The eluates containing purified Ecm18 was taken for the next step of purification – anion 
exchange chromatography (AEC) using Hi Trap
TM 
5 ml Q Sepharose XL ion-exchange 
column. 
The purification was carried out using the following buffers - 20 mM Tris-HCl, 1 mM DTT, 
1 mM EDTA and 20 mM Tris-HCl, 1 mM DTT, 1 mM EDTA, 1 M NaCl.  Ecm18 elutes out 
at a concentration of 37 to 43% NaCl.  The final step of purification was carried out using 
size exclusion chromatography (SEC) using Superdex 200 – 10/300 GL gel filtration column 
in the buffer containing 20 mM Tris-HCl, 1 mM DTT, 1 mM EDTA pH 7.8. The purity of the 
protein was checked by running the fractions from each round on a 4-12% SDS-PAGE gel 








Figure 16. Ecm18 protein purification – Nickel affinity purification and anion exchange 
chromatography. (a) Ecm18 expression; M-1 kB Mol Wt marker; L2- Uninduced cell lysate; (b) 
Ni
2+
 affinity purification of Ecm18; M-1 kB Mol Wt marker; L2 - Clear lysate; L3- protein unbound 
to nickel beads; L4 & L5-Washes; L6 to L10- Protein eluates in different concentrations of imidazole; 
The elutes from the affinity purification step (L6 to L10) are pooled together for the next round of 
purification; (c) Anion Exchange chromatography profile of Ecm18. The purification was carried out 
using Buffer A 20 mM Tris-HCl, 1 mM DTT, 1 mM EDTA pH 7.8 and Buffer B  20 mM Tris-HCl, 1 






Figure 17. Ecm18 protein purification – Size exclusion chromatography. (a) Size exclusion 
chromatography profile of Ecm18 purified in the Buffer containing 20 mM Tris-HCl, 1 mM DTT, 1 
mM EDTA pH 7.8. Ecm18 elutes out at a volume of around 13.6 ml; (b) Purified Ecm18 exhibiting a 
single band on a 4-12% SDS-PAGE gel. 
 
2.4 Protein confirmation by MALDI TOF-TOF analysis 
In order to determine the identity of the purified protein, it was run on a 4-12% SDS-PAGE 
gel.  A single band corresponding to the protein Ecm18 around 30 kDa was observed. This 
was cut using a cutting blade. The extracted band was submitted for MALDI TOF-TOF mass 
spectrometry analysis. The band was initially subjected to tryptic digestion to obtain smaller 
fragments and the fragments obtained were further analysed using tandem mass-
spectrometry. It was confirmed that the purified protein was Ecm18 from Streptomyces 
lasaliensis (result in Appendix 4). 
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2.5 Protein Characterisation 
2.5.1 Circular Dichroism (CD) spectroscopy 
CD spectroscopy is used for estimating the secondary structure content of proteins (Kelly SM 
2000; Greenfield 2006). The experiment was carried out using a Jasco J-810 
Spectropolarimeter in quartz cell with a path length of 1 mm. The CD spectra of purified 
Ecm18 was recorded at 20 °C at a concentration of 0.15 mg/ml in the buffer - 20 mM Tris-
HCl, 1 mM DTT, 1 mM EDTA pH 7.8. The spectrum of the buffer was subtracted for 
correction.  CD spectroscopy analysis of Ecm18 revealed the presence of α-helices and β-
sheets in its secondary structure. The CD spectra obtained for the purified Ecm18 is shown in 
Figure 18. 
 
Figure 18. CD spectra of purified Ecm18. CD spectra of Ecm18 shows the presence of α-helices and 
































2.5.2 Dynamic Light Scattering (DLS) 
Dynamic Light Scattering analysis is carried out to determine the size distribution profiles of 
protein molecules in solution and to check the homogeneity of protein solution (Noel A. 
Clark 1970; Pecora 1975). DLS experiment was carried out using Protein solutions DynaPro 
instrument in quartz cell with 1 cm path length and the data was analysed using DYNAMICS 
V6 software. The DLS profile of purified protein Ecm18 was recorded at 20 °C at a 
concentration of 5.0 mg/ml in the buffer - 20 mM Tris-HCl, 1 mM DTT, 1 mM EDTA pH 
7.8. From the DLS analysis, it was observed that Ecm18 exists as monomer at a concentration 





Figure 19. Dynamic Light Scattering profile of Ecm18. The size distribution profile obtained for 
Ecm18 was analysed using DYNAMICS V6. From the DLS profile, the apparent molecular weight of 




2.6 Protein crystallisation 
We have attempted to crystallise Ecm18 under the following conditions.  
a) Ecm18 protein. 
b) Ecm18 in complex with S-Adenosyl-Methionine (SAM) [Enzyme + methyl group 
donor]. 
c) Ecm18 in complex with triostin A and sinefungin (SAM analogue) [Enzyme- 
substrate complex that will not turn over]. 
d) Ecm18 in complex with echinomycin + S-Adenosyl-Homocysteine (SAH) [Enzyme + 
product + by-product]. 
The structures of SAM, SAH and sinefungin are displayed in (Figure 20). 
 
Figure 20. Chemical structures of SAM, SAH and Sinefungin. SAM is the common methyl group 
donor for the SAM-dependent MTases. The methyl group is attached to the positively charged 
sulfonium ion (–S+–CH3–); SAH is the by-product obtained after the removal of methyl group from 




Crystallisation trials were carried out at room temperature by hanging drop vapour-diffusion 
method. The crystal screening was carried out using various screening kits from Hampton 
Research from Hampton Research, Qiagen NeXtal Suites and Jena Bioscience screens. The 
size of the hanging drop used for initial screening was 2 µl a mixture of 1 µl protein and 1 µl 
reservoir drop. Initially crystals were obtained for Ecm18-triostin A-sinefungin condition and 
Ecm18-echinomycin-SAH condition. Those crystals were further optimized by varying the 
drop size, protein concentration, protein-ligand ratio, buffer conditions to get diffraction 
quality crystals. The Ecm18-triostin A-sinefungin crystals obtained were not of good quality 
(needles). 
Good crystals were obtained for Ecm18-echinomycin-SAH condition after several rounds of 
optimisation under the following conditions: (i) 0.1 M Na cacodylate pH 6.5, 0.2 M Na 
acetate, PEG 8000 - 28% (w/v) and (ii) 0.1 M Na cacodylate pH 6.1, 0.2 M sodium acetate, 
PEG 8000 - 30% (w/v) (crystal drop size - 4 µl (2 µl protein mixture + 2 µl reservoir 
solution). The crystals from these conditions were further optimised using additive screen kit 
from Hampton Research. Diffraction quality crystals were obtained for the above mentioned 
conditions in the presence of 2.7% (w/v) of sucrose / 2.7% (w/v) of D-glucose monohydrate. 
The diffraction of these crystals was tested using the Rigaku home-source beamline. High 
resolution diffraction dataset of 2.83 Å was collected for one of the crystals from Spring-8 
synchrotron facility, Hyogo, Japan. The diffraction dataset could not be indexed because of 
the problem of high mosaicity and twinning in the crystal. 
In order to improve the crystals’ diffraction properties, the conditions were further optimised 
by varying the buffer conditions and protein concentration. The best diffracting crystals after 




Figure 21. Images of crystals obtained for Ecm18 - echinomycin- SAH complex. The crystal 
conditions for these hits are (a) Ecm18 : SAH : Echinomycin  -  1 : 14 : 1.6 (molar ratio); Buffer 
condition - 0.1 M Na cacodylate  pH 6.1, 0.2 M Na acetate trihydrate, PEG 8000 - 30% (w/v), 
ethylene glycol – 14% (v/v), Additive: sucrose - 2.7% (w/v); (b) Ecm18 : SAH : echinomycin  - 1 : 14 
: 1.6 (molar ratio); Buffer condition - 0.1 M Na cacodylate pH 6.1, 0.2 M sodium acetate trihydrate, 
PEG 8000 - 30% (w/v), ethylene glycol – 14% (v/v), Additive: D-glucose monohydrate - 2.7% (w/v); 
Drop size was 4.4 µl - 2 µl (protein mixture) + 2 µl (reservoir solution) + 0.4 µl additive. 
 
These crystals were further subjected to cryo-protection and dehydration using cryo-
protective agents such as glycerol, PEG 400. The crystals were subjected to quick dip in 
mother liquor containing various concentrations [5 to 20% (v/v)] of glycerol and PEG 400 
(Figure 22a) (Garman 1999). Two different dehydration techniques were employed to 
improve the crystal packing. In the first method, the crystals were subjected to air 
dehydration for various time intervals. In the second method,  mother liquor with 5% (v/v) 
dehydrating agent solution was added to the crystal drop and then transferred to reservoir 
solution containing the dehydrating agent and incubated for various time periods (15 hrs, 2 





Figure 22. Optimisation of Ecm18 crystals (Heras and Martin 2005). (a) Optimisation by cryo 
protection was carried out by adding a drop of cryo-protecting agent such as ethylene glycol or 
glycerol to the crystal drop prior to freezing in liquid nitrogen (Heras and Martin 2005); (b) Cryo 
protection by dehydration. Two methods of dehydration were employed; Air dehydration - 
dehydrating solution (about five times the crystallisation drop volume) was slowly added to the drop 
containing the crystal; the drop was then exposed to air for 15 minutes to 30 minutes to undergo 
dehydration; Dehydration and equilibriation – dehydrating solution (about five times the 
crystallisation drop volume) was slowly added to the drop containing the crystal and the drop was 
allowed to equilibrate against a reservoir with the same dehydrating solution. Dehydrating agents used 





2.7 X-Ray data collection 
The crystals optimised were subjected to flash-freezing in liquid nitrogen.  X-ray diffraction 
data set were collected for Ecm18 crystals at the IMCA-CAT 17ID beamline at the Advanced 
Photon Source in the Argonne National Laboratory using Dectris Pilatus 6M pixel array 
detector by Dr. Kim Chu-Young. A high resolution dataset of 1.5 Å was collected from a 
crystal which was subjected to 15 hour dehydration in mother liquor containing 5% (v/v) 
glycerol [Ecm18 concentration – 3.7 mg/ml; 0.1 M Na Cacodylate pH 6.1, 0.2 M Na acetate 
trihydrate, PEG 8000 - 30% (w/v), ethylene glycol - 14% (v/v), sucrose - 2.7% (w/v)]. The 
diffraction data were processed and scaled using HKL2000. Data processing statistics are 
presented in Table 1. 
 
Table 1.  X-ray data collection statistics for Ecm18 
Data Collection  
Space group P 1211 
Cell dimensions  
a,b,c (Å) 58.19, 146.88, 58.19 
α, β, γ (°) 90.00, 102.63, 90.00 
Resolution (Å) 1.50 
No. of total reflections 357753 
No. of unique reflections 53910 
Rmerge 0.116 
I/σ (I) 11.7 






2.8 Phase determination and model building 
Based on the sequence information and homology modelling, it is found that Ecm18 has a 
highly conserved core α/β Rossmann-like fold.  I carried out molecular replacement (MR) 
using the program MOLREP (Vagin A 2010) to obtain the phase information with the 
available homologue structures as templates. But a good molecular replacement solution 
could not be obtained for Ecm18 using MOLREP. 
The structure was later solved using the program AMPLE by Dr. Kim Chu-Young. AMPLE 
is not publicly available. This program uses Rosetta based ab-initio model building to 
generate a template model for molecular replacement based phase determination.  Model 





Refinement is currently being carried out using REFMAC 5.6 (Murshudov, Vagin et al. 1997; 
Afonine, Grosse-Kunstleve et al. 2012). TLS (translation/liberation/screw groups) restraints 
were applied among the 4 molecules of the asymmetric unit during refinement. The Rwork and 
Rfree values of the currently refined structure are 0.18 and 0.22 respectively. The geometry of 
the model was checked using PROCHECK (Laskowski, MacArthur et al. 1993). 0.7% 
residues (8 amino acids - Asp-169 and Asp-170 in all four molecules in the asymmetric unit) 
lie in the disallowed region. It is not unusual to have 2 residues out of 237 residues to lie in 
the disallowed region. This is a high resolution (1.5 Å) structure and the electron density map 
corresponding to Asp-169 and Asp-170 is clearly defined (Figure 23).  
 
 
Figure 23. Fo – Fc electron density map of the region surrounding Asp-169 and Asp-170. The map is 
contoured at 3 σ.  
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Relevant refinement statistics are presented in Table 2. 
Table 2. Refinement statistics for Ecm18 
Structure Refinement  







No of reflections  
Working set 143561 
Test set 7689 
R
msd
 from ideal values  
Bond length (Å) 0.027 
Bond angles (° ) 3.122 
Average B factor (Å
2
) 18.568 
Ramachandran plot  
Most favoured regions (%) 99.5 
Generously allowed regions (%) 0.6 



























3.1 Quality of the structure 
The currently refined crystal structure reveals the presence of the enzyme Ecm18 in complex 
with echinomycin and SAH. In the crystal structure, each molecule of Ecm18 encloses one 
molecule of SAH and one molecule of echinomycin. The electron density maps of the two 
ligands are clearly seen in the 2Fo – Fc omit map (Figure 24). There are 4 molecules in an 
asymmetric unit but the 4 molecules do not exhibit significant crystal contact. Also from the 
size exclusion chromatography and dynamic light scattering analysis, we know that Ecm18 
behaves as a monomer in solution. Hence the observation of four molecules of Ecm18 in the 
asymmetric unit is not biologically relevant. The four molecules have an RMS deviation of 
0.35 Å. 
 
3.2 Overview of the structure 
From the solved crystal structure, it can be seen that the tertiary structure of Ecm18 is made 
up of 10 α-helices and 7 β-strands (Figure 24). Ecm18 reveals the presence of core α/β 
Rossmann-like fold characterising the MTase domain. The structure of Ecm18 shows the 
presence of a helix near the C-terminal end. But this helix does not form part of the coding 





Figure 24. Ecm18-echinomycin-SAH ternary complex. (a) Ribbon representation of Ecm18-
echinomycin-SAH complex structure. Ecm18 is shown as cartoon; echinomycin and SAH are 
represented in sticks. The core α/β Rossmann-like fold is coloured in slate; the substrate binding 
domain is coloured in grey; the additional helix near the C-terminal is coloured in limegreen; the loop 
regions are coloured in light pink. SAH and echinomycin are coloured in green and cyan respectively; 
(b) Fo-Fc electron density omit map of SAH. The map is contoured at 3 I/σ.  (c) Fo-Fc electron density 
map of echinomycin. The map is contoured at 3 I/σ. 
 
Search for structurally similar proteins was carried out using the database DALI (Holm and 
Park 2000). DALI results (table in Appendix 5) indicate that Ecm18 exhibits structural 
alignment with many SAM-dependent MTases in the SAM-binding domain (Rossmann-like 
fold) , whereas the other domain exhibits significant variation.   
The highest structural similarity was observed with Q8PUK2_METMA, a SAM-dependent 
MTase from Methansosarcina mazei (PDB code - 3SM3, Chain A) [Z-score – 20.4 and RMS 
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deviation – 2.9 Å]. The structural overlay of Ecm18 with this homologue shows very high 
conservation of Rossmann-like fold.  But the substrate binding domains of the two structures 
show significant difference. Ecm18 has two α-helices, a 310 helix and two β-strands in its 
substrate binding domain whereas Q8PUK2_METMA has one α-helix and four β-strands 
(Figure 25).  
The next hit was OT3, a putative MTase from Pyrococcus horikoshii (PDB code – 1VE3, 
Chain A) [Z-score – 20.3 and RMS deviation – 2.9 Å]. The Rossmann-like fold is conserved 
across Ecm18 and OT3. In the substrate binding domain, there is partial conservation of the 
α-helices but the orientation and the number of β-strands forming the β-sheet in the two 
structures is very different (Figure 25). 
 
 
Figure 25. Structural overlay of 
Ecm18 with close homologues 
predicted from DALI. (a) Ecm18 is 
coloured in slate; Chain A of 
Q8PUK2_METMA, a SAM-dependent 
MTase is coloured in salmon. (b) 
Ecm18 is coloured in slate; Chain A of 
OT3, a putative MTase is coloured in 
salmon. The structural overlay exhibits 
the conservation of Rossmann-like fold 
of Ecm18 with the identified 
homologues. The substrate binding 
domain of Ecm18 shows variation in 
the structural fold.  
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3.3 Conserved Rossmann-like fold / SAM-binding domain 
This highly conserved structural fold encompasses the SAM-binding domain and forms the 
major portion of catalytic domain of this class of MTases. This domain consists of 6 α-helices 
named αZ, αA, αB, αC, αD and αE and 7 β-strands named β1, β2, β3, β4, β5, β6 and β7 
forming the central planar β-sheet. As depicted in Figure 26, the β-sheet in Ecm18 has the 
following topological arrangement – β3↑-β2↑- β1↑- β4↑ -β5↑ -β7↓- β6↑, surrounded by α-
helices on both sides. 
3.3.1 Conserved motifs involved in SAM/SAH binding 
Although the Rossmann-like fold in SAM-dependent Mtases do not exhibit very high 
sequence identity, they show significant conservation of certain motifs involved in 
SAM/SAH binding (Schluckebier, O'Gara et al. 1995).  The conformation and the orientation 
of SAM/SAH in this domain are also highly conserved among the members of this class 
(Cheng and Blumenthal 1999). The structure of Ecm18 shows the conservation of SAM 
binding motifs in it. 
The motif I (coloured orange in Figure 26), encompasses the β1-strand and the loop region 
connecting β1 and αA-helix. The β1-strand has a well conserved acidic residue (43-VLDA-
46) which polarises a water molecule near the methyl group of SAM to facilitate nucleophilic 
attack of the methyl group. The loop region of this motif is ‘’glycine-rich” and is the most 
important signature motif of the Rossmann-like fold in SAM-dependent MTases. Ecm18 
contains (47-GCGTG-51) in its loop region which interacts with the hydroxyl propyl moiety 
of SAH. The motif II (coloured purple in Figure 26) comprises of the β2-strand and part of 
the loop region connecting β2-strand and αB-helix (64-VTGLDL-69). The conserved acidic 
residue at the end of β2-strand (Asp-68) forms hydrogen bond with the ribosyl hydroxyl 
residue. Some of the residues of this motif also interact with the nitrous base. Motif IIII 
(coloured in red in Figure 26) is made up of residues present near the end of the β4 strand 
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(108-VIDS-111) which are involved in various interactions with the methionine moiety of the 




3.4 Substrate binding domain 
The substrate binding domain of Ecm18 is composed of two α-helices, a 310 helix and two β-
strands. Of the three helices, one is found near the N-terminus, the second α-helix and the 310 
helix are located in between the β5 and αE of the Rossmann-like fold (SAM-binding 
domain). The two β-strands of the substrate binding domain are antiparallel and are located 
between the β6 and β7 strands of the Rossmann-like fold. The presence of an α-helix near the 
N-terminal is commonly observed in most SAM-dependent MTases (Martin and McMillan 
2002).  
Figure 26. Rossmann-like fold 
conserved in Ecm18. Ribbon 
representation of the conserved core 
α/β Rossmann-like fold in Ecm18. 
The helices are labelled as αZ, αA, 
αB, αC, αD and αE; the strands are 
labelled as β1, β2, β3, β4, β5, β6 and 
β7. The β7 is antiparallel indicating 
the SAM-MT fold in Ecm18. The β-
sheet is planar and is surrounded by 
α-helices on both sides. The amino 
acids of this domain are involved in 
binding the cofactor SAM/SAH. The 
SAH is represented in sticks and is 
coloured in green. The conserved 
motifs involved in SAM/SAH 
binding are coloured in orange (motif 




Insertion of an additional α-helix to the core between β6 and β7 of the core Rossmann-like 
fold is usually observed in MTases which methylate small molecules. The insertion of an α-
helix between β5 and αE has been observed only recently in a O-MTase, DhpI (Lee, Bae et 
al. 2010) which acts on phosphonate substrates. DhpI (PDB code -3OU2) exhibits 32% 
sequence identity with Ecm18. 
The substrate binding domain of Ecm18 is composed of a rich set of hydrophobic amino 
acids residues. Residues such as Val-4, Phe-5, Ala-7, Val-8, Pro-14, Ile-144, Met-152, Ile-
163, Ala-165, Pro-166, Ala-176 and Met-201 lie within a distance of 6 Å with echinomycin 
in the currently refined structure (Figure 27). Some polar amino acids involved in interaction 
with the substrate are His-115, Thr-116 and Gln-153. 
                       
Figure 27. Region of echinomycin-Ecm18 interaction. Amino acid residues interacting with 
echinomycin (within a distance of 6 Å) are shown. Echinomycin binding site in Ecm18 reveals the 
presence of many hydrophobic amino acids and few polar residues. The residues that are involved in 
various interactions with echinomycin are represented as lines, coloured in green and labelled. 




3.5 Conformation of echinomycin in Ecm18 
One of the most interesting observations from the crystal structure is the conformation of 
echinomycin. Echinomycin found in the binding pocket of Ecm18 adopts a folded 
conformation whereas in the previously determined structures, echinomycin is in complex 
with DNA and adopts an extended conformation (Figure 28). Comparison of the structures of 
echinomycin in the two conformations reveal that the distance between the two chromophore 
rings is reduced by half in echinomycin bound to Ecm18. 
Based on this observation, we infer that this conformation is required for the cyclic peptide to 
bind into the substrate binding pocket of Ecm18. The enzyme could be involved in folding 
the substrate. The two quinoxaline chromophores of echinomycin in this structure lie within 
the operating distance of parallel displaced pi-pi stacking interaction. This kind of pi-pi 
stacking interaction can operate within a range of 7.5 Å (McGaughey, Gagne et al. 1998) 
between the two pi electron systems and in our case the distance is about 4 Å (Figure 28). 
This interaction appears to play an important role in stabilising echinomycin in this folded 
conformation which is required for its binding into the enzyme pocket. The exact mechanism 





Figure 28. Conformational change in echinomycin. (a) In Ecm18 ternary complex, echinomycin 
adopts a folded conformation. The distance between the chromophore rings is around 4 Å. The 
distance and the position of the chromophore rings suggest the presence of parallel displaced pi-pi 
stacking interaction between the rings. Echinomycin is represented in sticks and coloured in cyan; (b) 
Stick representations of previously determined structures of echinomycin in complex with 
oligonucleotides. In all these complexes echinomycin adopts an extended conformation. The distance 
between the chromophore rings in these structures is around 10 Å. The echinomycins are denoted by 
their PDB code. Echinomycin in complex with (CGTACG)2 from Streptomyces echinatus (PDB code 
– 1XVR) coloured in lightpink, echinomycin in complex with (ACGTACGT)2  from Streptomyces 
echinatus (PDB code – 1XVN) coloured in violet, echinomycin in complex with (GCGTACGC)2 
from Streptomyces echinatus (PDB code – 1PFE) coloured in salmon, echinomycin in complex with 
(ACGTACGT)2 and Mg
2+





3.6 Elucidation of the mechanism of action of Ecm18 
Ecm18 is speculated to catalyse the methyl transfer via nucleophilic attack as possess 
Rossmann-like fold in its catalytic domain.  This is supposedly followed by a proton 
abstraction step which is carried out by a base from the enzyme Ecm18. The proton 
abstraction step leads to the formation of a dipolar intermediate (sulfur ylide intermediate) 
(Anthony G. M. Barrett, Dieter Hamprecht et al. 1997; Van Lanen and Iwata-Reuyl 2003).  
This intermediate undergoes bond rearrangement which is proposed to take place via the 
formation of a transition state which has to be stabilised by a residue from the enzyme 
Ecm18. The stabilisation of the transition state facilitates bond rearrangement which leads to 






Figure 29. Proposed mechanism of action of Ecm18 in the conversion of triostin A to echinomycin 
(credit: Fang Minyi). Chemdraw representation of the proposed enzymatic reaction mechanism for the 
biotransformation of disulfide bond to thioacetal link formation. This mechanism is based on a 
mechanism proposed earlier for Ecm18 (Watanabe K, Praseuth AP et al. 2009). (i) The first step in 
the biotransformation is the transfer of methyl group from SAM to one of the sulfur atoms of triostin 
A by means of nucleophilic attack mediated by the enzyme Ecm18; (ii) Abstraction of proton 
abstraction from the carbon atom next to the sulfur that is methylated by a base from Ecm18; (iii) 
Formation of sulfur ylide intermediate as a result of base abstraction step; (iv) The sulfur ylide 
intermediate has a tendency to undergo bond rearrangement (Anthony G. M. Barrett, Dieter 
Hamprecht et al. 1997; Van Lanen and Iwata-Reuyl 2003). (v) Formation of a transition state with an 
overall positive charge involving stabilisation by Ecm18; (vi) Spontaneous bond rearrangement as a 
result of formation of the transition state producing thioacetal link, producing echinomycin.    
 
3.6.1 Methylation by nucleophilic attack 
The first step in the conversion of triostin A to echinomycin is the transfer of methyl group 
from SAM to any one of the sulfur atoms of triostin A. From the structure of Ecm18, we 
know that it exhibits Rossmann-like fold.  SAM-dependent methyl transfer reactions 
catalysed by this class of SAM-dependent enzymes is by means of nucleophilic attack 




Figure 30. Relative orientation of substrate and cofactor in Rossmann-like fold MTases. (a) Relative 
orientation of Echinomycin and SAH in Ecm18. The linear arrangement of the by-product and the 
product in Ecm18 indicating the methyl transfer catalysed by means of nucleophilic attack. SAH and 
echinomycin are represented as sticks. SAH is coloured in green and echinomycin in cyan. The amino 
acid residues surrounding this region are represented as lines, labelled and coloured in green; (b) 
Relative orientation of SAH and substrate in structurally characterised MTases. In these MTases the 
linear arrangement of by-product and substrate explains the significance of the structural fold 
(Rossmann-like fold) in facilitating methyl group transfer via nucleophilic attack. The SAH and the 
substrate are represented as sticks and coloured in green. The MTases are denoted by their name and 
PDB code. Chalcone O-MTase from Medicago sativa (PDB code – 1FP1), Isoflavone O-MTase from 
Medicago truncatula (PDB code – 2QYO). Surrounding amino acid residues are represented as lines 
and coloured in green. 
 
The relative arrangement of echinomycin with respect to the SAH molecule in the currently 
determined crystal structure appears to be linear. This kind of linear arrangement of the 
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methyl group donor and the acceptor molecule facilitates the attack of the methyl group from 
SAM by nucleophilic centres on the acceptor molecule. This spatial orientation of the 
methylated sulfur atom in echinomycin and SAH in Ecm18-ternary complex is consistent 
with the arrangement found in other MTases facilitates nucleophilic attack (Zubieta, He et al. 
2001; Rutherford, Le Trong et al. 2008; Singh, McCoy et al. 2008). 
 
3.6.2 Putative catalytic residues in Ecm18 
According to the proposed mechanism, the role of Ecm18 is required in two steps in the 
conversion of triostin A to echinomycin. 
3.6.2.1 Proton abstraction 
The second step in the conversion of triostin A to echinomycin is the abstraction of a base 
from the carbon atom next to the sulfur atom of the methylated triostin A. The proposed 
mechanism suggests that a base from the enzyme is involved in this step (Watanabe K, 
Praseuth AP et al. 2009). In order to identify the residue that could act as a potential base, the 
sequence of Ecm18 was compared with the sequence of structurally characterised small-
molecule MTases. From the sequence alignment table (Figure 33), it can be seen that 
histidine at the position 115 of Ecm18 is highly conserved across small molecule MTases. 
Also it has to be noted that histidine has been identified as the putative catalytic residue in 
these MTases. 
His 115 is located on the αC helix of the core α/β Rossmann-like fold of Ecm18 (Figure 31). 
Investigation of the active site of Ecm18 clearly reveals the presence of His 115 in close 
proximity to echinomycin. The basic nitrogen of histidine is within a distance of 4.2 Å from 
the carbon atom of echinomycin that has undergone proton abstraction. Based on these 
49 
 
observations from the crystal structure, we propose that the basic nitrogen of histidine is the 
base involved in the deprotonation step. 
 
Figure 31. Histidine 115 - putative catalytic base. (a) Cartoon representation of the active site of 
Ecm18 encompassing a basic residue histidine at the position 115. His-115 is present on the αC helix 
of the core Rossmann-like fold. The distance between the nitrogen base of His-115 and the C- atom 
on echinomycin in this crystal structure is 4.2 Å (represented by yellow dashed line). Echinomycin 
and SAH are represented in sticks; echinomycin is coloured in cyan and SAH in green. His-115 is 
coloured in purple. Some structural regions of Ecm18 around the active site have been omitted for the 
purpose of clarity; (b) Chemdraw representation of the mechanism of proton abstraction mediated by 
His-115 of Ecm18. The abstraction of base from the C-atom of the substrate by the basic nitrogen of 
histidine is illustrated by an arrow. 
 
3.6.2.2 Stabilisation of a transition state  
Following the proton abstraction step is the formation of an ylide intermediate. Ylides are 
dipolar molecules and they are usually formed as reaction intermediates. This intermediate 
has to undergo bond rearrangement to form the thioacetal linkage found in the final product 
echinomycin. According to the proposed mechanism (Watanabe K, Praseuth AP et al. 2009), 
the bond rearrangement occurs via the nucleophilic attack on the neutral sulfur atom by the 
carbanion of the ylide intermediate. There is also cleavage of the disulfide bond of the 
cysteine residue taking place simultaneously. 
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The torsion angle between the atoms involved in the bond rearrangement is very large and 
hence does not permit spontaneous rearrangement. This constraint makes the rearrangement 
to be a highly energy requiring process. An enzyme’s involvement is necessary to reduce the 
energy barrier and catalyse this reaction. At this stage, we propose the formation of a 
transition state formed in the presence of Ecm18.  
This transition state involves partial cleavage of the disulfide bond and partial bond formation 
between the carbanion and the neutral sulfur atom with an overall positive charge. This 
positive charge has to be stabilised by a pi electron system (aromatic amino acids) from the 
enzyme Ecm18. The crystal structure reveals the presence of two aromatic residues, Phe-5 
and Trp-21 near the region of transition state. We report Phe-5 and Trp-21 to be the putative 
residues involved in catalysing this step (Figure 32). 
 
Figure 32. Putative residues of 
Ecm18 involved in transition state 
stabilisation. (a) Transition state 
formation in echinomycin. 
Echinomycin and the two aromatic 
amino acids Phe-5 and Trp-21 of 
Ecm18 found near this region are 
represented as sticks and coloured in 
green. These are the putative 
residues that are involved in 
transition state stabilisation. 
Echinomycin is coloured in cyan; (b) 
Chemdraw representation of the 
transition state stabilisation requiring 
aromatic amino acids (pi electron 
system) for stabilisation. Two 
aromatic amino acids Phe-5 and Trp-




3.7 Multiple Sequence alignment of Ecm18 with small molecule MTases 
 
Figure 33. Multiple sequence alignment of Ecm18 with structurally characterised small molecule 
MTases. Protein sequences of structurally characterized MTases are denoted by their name. Mycolic 
acid synthase Hma (Mmaa4) from Mycobacterium tuberculosis (PDB code -2FK8), Mycolic acid 
cyclopropane synthase (Cmaa1) from Mycobacterium tuberculosis (PDB code- 1KPH), 
Rebeccamycin, a sugar O-MTase from Lechevalieria aerocolonigenes (PDB code – 3BUS), sarcosine 
dimethylglycine MTase (GNMT) from Galdieria sulfuraria (PDB code – 2O57), carcinomycin  4-O-
MTase (DnrK) from Streptomyces peucetius (PDB code – 1TW3), Ecm18 from Streptomyces 
lasaliensis and DphI, a phosphonate O-methyltransferase from Streptomyces ludicrous (PDB code -
3OU2). Red highlight denotes the amino acid residue histidine conserved across all small molecule 




The sequence alignment of Ecm18 with other small molecule MTases (Figure 33) indicates 
moderate conservation of Phe-5 residue, whereas the Trp-21 is not conserved across the 
members of this class. This suggests that Ecm18 has unique catalytic properties over other 



















We report the partially refined crystal structure of Ecm18 in complex with the product 
(echinomycin) and by-product (SAH). The structural elucidation has enabled us to 
characterise the different domains (catalytic and substrate binding domain) of Ecm18. The 
high resolution crystal structure has also enabled the identification of the putative catalytic 
residues involved in the biotransformation of disulfide bond to thioacetal group resulting in 
the synthesis of echinomycin.  
The SAH/SAM binding domain (catalytic domain) possesses the core α/β Rossmann-like fold 
which is highly conserved across the other MTases. This structural fold is responsible for 
binding the cofactor and facilitating the nucleophilic transfer of methyl group to the substrate. 
The arrangement of SAH and echinomycin in the current structure validates the mode of 
methylation catalysed by Ecm18. 
Preliminary investigation regarding the type of interactions and the residues involved in 
substrate binding has been carried out. The substrate binding region reveals the presence of 
multiple hydrophobic amino acids (Val-4, Phe-5, Ala-7, Val-8, Pro-14, Ile-144, Met-152, Ile-
163, Ala-165, Pro-166, Ala-176 and Met-201) and a few polar residues (His-115, Thr-116 
and Gln-153) within the range of interaction with echinomycin. 
Echinomycin in this crystal structure adopts a closed form whereas in the previously 
determined DNA-bound structures, it adopts an open form. In this conformation, the distance 
between the chromophore rings of echinomycin is reduced by half.  
Phe-5, Trp-21 and His-115 have been identified as the putative catalytic residues in the 
conversion of trisotin A to echinomycin. His-115 is the putative catalytic base and the two 




4.2 Future work 
Detailed investigations regarding the structure and the substrate binding specificity of the 
enzyme will be carried out with the fully refined structure. 
In order to validate the interpretations of the current work, mutagenesis experiments may be 
carried out. This can, in principle, further verify the role of putative catalytic residues so far 
identified (Phe-5, Trp-21 and His-115). 
The effect of each residue on the functioning of Ecm18 will be studied by mutating the 
particular residue with alanine (Lefevre, Remy et al. 1997). Ecm18 variants will be generated 
by site-directed mutagenesis. The effect of alanine mutation on the activity of Ecm18 will be 
evaluated by comparing the activity of the wild type protein with that of the mutants 
generated on its ability to convert triostin A to echinomycin. The thioacetal formation assay 
will be carried out using an established protocol (Watanabe K 2006). This will help in 
validating the interpretations made from the crystal structure and in turn help us in 
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Appendix 1  
 
Ecm18 - amino acid sequence 
Organism: Streptomyces lasaliensis 






Sequence of Ecm18 encoded by the gene  







Number of amino acids: 263 aa 
Molecular weight: 28295.4 Da 
Theoretical pI: 5.46 























1 BAE.98167.1 446 100% 100% 
putative SAM-dependent MTase 
from  Streptomyces lasaliensis 
2 BAH.04163.1 315 100% 68% 
putative SAM-dependent MTase 
from  Streptomyces triostinicus 
3 AET.98907.1 309 100% 67% 
putative SAM-dependent MTase 
from Streptomyces griseovariabilis 
subsp. bandungensis 
4 BAI.63280.1 233 99% 52% 
putative SAM-dependent MTase 
from  Streptomyces sp. SNA15896 
5 YP 001104254.1 159 98% 43% 
MTase type 11 from 
Saccharopolyspora erythraea NRRL 
2338 
6 YP 001105422.1 161 99% 44% 
Hypothetical protein SACE_3222  
from Saccharopolyspora erythraea 
NRRL 2338 
7 ZP 06563621.1 161 99% 44% 
Hypothetical protein SeryN2_14104 
from Saccharopolyspora erythraea 
NRRL 2338 
8 YP 937604.1 151 98% 43% 
Type 11 MTase from Mycobacterium 
sp. KMS 
9 YP 003512665.1 152 85% 44% 
Type 11 MTase from Stackebrandtia 
nassauensis DSM 44728 
10 ABO15858.1 150 97% 45% 







PDB-BLAST result for Ecm18 








1 1VE3 54.5 69% 29% 
PH0226 protein from Pyrococcus 
horikoshii OT3 
2 1WZN 54.5 46% 40% 
SAM-dependent MTase from 
Pyrococcus Horikoshii OT3 




4 3OU2 46.9 74% 32% 
DphI, a phosphonate O-MTase from 
Streptomyces luridus 
5 2XVA 40.1 47% 28% 
Tellurite detoxification protein TehB 
from Escherichia coli str. K-12 
substr.MG1655 
6 3BUS 38.4 44% 38% 














Structural matches of Ecm18 – DALI results 












20.4 2.9 180 6 SAM-dependent methyltransferases 








20.1 2.6 183 8 SAM-dependent halide 








19.9 2.9 190 5 SAM-dependent methyltransferase 
from Pyrococcus Horikoshii OT3 
6 3H2B 
(Chain A) 
19.2 2.3 172 10 SAM-dependent methyltransferase 




19.0 3.1 174 7 YcgJ protein from Bacillus subtilis 
 
 
